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OBJECTIVES The purpose of our study was to evaluate patients with suspected anomalous pulmonary veins
(APVs) and atrial septal defects (ASDs) using fast cine magnetic resonance imaging (MRI)
and ultrafast three-dimensional magnetic resonance angiography (MRA).
BACKGROUND Precise anatomic definition of anomalous pulmonary and systemic veins, and the atrial
septum are prerequisites for surgical correction of ASDs. Cardiac catheterization and
transesophageal echocardiography (TEE) are currently used to diagnose APVs, but did not
provide complete information in our patients.
METHODS Twenty consecutive patients with suspected APVs were studied by MRA after inconclusive
assessment by catheterization, TEE or both. The MRI images were acquired with a fast cine
sequence and a novel ultrafast three-dimensional sequence before and after contrast injection.
RESULTS Partial anomalous pulmonary venous drainage was demonstrated in 16 of 20 patients and was
excluded in four patients. Magnetic resonance imaging correctly diagnosed APVs and ASDs
in all patients (100%) who underwent surgery. For the diagnosis of APVs, the MRI and
catheterization results agreed in 74% of patients and the MRI and TEE agreed in 75% of
patients. For ASDs, MRI agreed with catheterization and TEE in 53% and 83% of patients,
respectively.
CONCLUSIONS Fast cine MRI with three-dimensional contrast-enhanced MRA provides rapid and com-
prehensive anatomic definition of APVs and ASDs in patients with adult congenital heart
disease in a single examination. (J Am Coll Cardiol 2001;37:1120–8) © 2001 by the
American College of Cardiology
Recent studies have underscored the importance of accurate
assessment of the number and the course of anomalous
pulmonary veins (APVs) in patients with atrial septal
defects (ASDs), especially of the sinus venous type (1–3).
Definitive diagnosis of anomalous pulmonary venous drain-
age (APVD) may be difficult by cardiac catheterization from
oximetry or levophase angiography, even when using selec-
tive pulmonary artery injection techniques (4,5). Diagnostic
difficulties are also encountered with transthoracic echocar-
diography (TTE) and transesophageal echocardiography
(TEE) (1,6); adults provide a greater challenge than chil-
dren due to more limited echocardiographic windows (7).
Detection rates for APVs using TEE have varied widely
(1,4,8). While conventional magnetic resonance imaging
(MRI) or computed tomography techniques can aid in
detection of these abnormalities (9–11), recent advances in
MRI sequences have increased the speed of image acquisi-
tion and improved the diagnostic utility of MRI (12).
Magnetic resonance angiography (MRA) methods were
adapted to the thorax and permitted noninvasive assessment
of vessel size, course and location in a multiplanar manner.
Initial MRA approaches used noncontrast-enhanced images
at lower field strength to evaluate APVs (13). Further
improvements in pulse sequence and gradient design now
permit high resolution three-dimensional (3D) examination
of the entire mediastinum in a single 10- to 30-s breath-
hold at 1.5-Tesla field strengths (14). Contrast-enhanced
MRA improves delineation of vessel borders and enables
3D reconstruction of the heart and great vessels, which can
establish unequivocally the presence of APVs and identify
their entire course through the lung parenchyma and me-
diastinum and their sites of drainage.
Magnetic resonance imaging, which is an established
method for evaluation of ASDs, has proven useful using
both spin echo and conventional cine gradient echo tech-
niques (15–17). In addition, recent advances have led to
precise identification of the size and shape of ASDs using
phase-contrast cine MRI methods (18). The advent of rapid
imaging using segmented k-space techniques has reduced
data acquisition time dramatically, allowing dynamic cine
MRI at a desired slice location in a single breath-hold,
which aids in localization of intracardiac shunts (19).
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Precise anatomic knowledge of the drainage of APVs,
location of associated ASDs and the presence of abnormal
systemic venous connections are important prerequisites for
planning optimal surgical repair (20).
The aim of this prospective study was to use these new
technologic developments in MRI and ultrafast 3D MRA
to define the anatomy of the pulmonary venous circulation
and the atrial septum in 20 consecutive adult patients with
suspected APVD and ASDs, in whom inconclusive diag-
nostic information was obtained at cardiac catheterization,
TTE and/or TEE.
METHODS
Patient population. We studied 20 consecutive adult pa-
tients (9 male and 11 female) aged 22 to 68 years (mean
42 6 13), with suspected APVD and/or ASDs. All were
referred specifically for ultrafast MRI and MRA to
determine the presence of APVs and ascertain the pres-
ence and anatomic location of the ASDs, because prior
cardiac catheterization data, TEE or both had proved
inconclusive.
The most common presenting symptoms were dyspnea
on exertion (75%), palpitations (40%) and fatigue (30%).
Two patients presented with atypical chest pain, and two
patients were seen in follow-up for a heart murmur. Two
patients had documented paroxysmal atrial fibrillation. Two
patients (10%) had multiple skeletal abnormalities including
short humeri, distal radio-ulnar synostoses, abnormal carpal
bones and bilateral digitization of the thumbs, consistent
with the hand-heart or Holt-Oram syndrome (21), and one
patient (5%) had Swyer-James syndrome with atresia of the
right pulmonary artery (22) (Table 1).
All patients were in sinus rhythm and were screened for
contraindications to MRI and MRA.
Magnetic resonance imaging and angiography. MR
IMAGING. All MRI was performed on a 1.5-T Signa
scanner (General Electric Medical Systems [GEMS], Mil-
waukee, Wisconsin), using an enhanced gradient system
Abbreviations and Acronyms
3D 5 three-dimensional
APV 5 anomalous pulmonary vein
APVD 5 anomalous pulmonary venous drainage
ASD 5 atrial septal defect
IVC 5 inferior vena cava
MRA 5 magnetic resonance angiography
MRI 5 magnetic resonance imaging
PA 5 pulmonary artery
Qp 5 pulmonary blood volume flows
Qs 5 systemic blood volume flows
Qp/Qs 5 shunt fraction
RUL 5 right upper lobe
SPGR 5 spoiled gradient
SVASD 5 sinus venosus atrial septal defect
SVC 5 superior vena cava
TE 5 echo time
TEE 5 transesophageal echocardiography
TR 5 repetition time
TTE 5 transthoracic echocardiography
Table 1. Diagnoses and Associated Findings After Testing or Surgery or Both
Patient # Age Diagnosis Associated Findings Other Congenital Disorders
1 54 Secundum ASD RPA atresia Swyer-James syndrome, many bronchial collaterals
2 53 Sinus venosus ASD APV RUL and RML to RSVC
3 39 Sinus venosus ASD APV RUL to RSVC PLSVC to coronary sinus
4 56 Secundum ASD APV RUL to RSVC
5 68 Secundum ASD APV LUL and LML to LBCV
6 55 Sinus venosus ASD APV RUL to RSVC
7 27 Sinus venosus ASD APV RUL and RML to RSVC
8 38 Scimitar syndrome APV RUL, RML, and RLL to IVC Imperforate anus, single kidney, short right leg
9 35 Sinus venosus ASD APV RUL to RSVC
10 29 Secundum ASD Restrictive apical VSD Holt-Oram syndrome
11 59 Secundum ASD
12 42 Sinus venosus ASD APV RUL and RML to RSVC PLSVC to coronary sinus
13 28 Secundum ASD Nonrestrictive membranous VSD Holt-Oram syndrome, left aortic arch but right
descending aorta, aberrant right subclavian
artery
14 47 Scimitar syndrome APV RUL and RML to IVC (Normal drainage of RLL PV to LA)
15 49 Sinus venosus ASD APV RUL and RML to RSVC PLSVC to coronary sinus, no LBCV seen
16 22 Sinus venosus ASD APV RUL and RML to RSVC PLSVC to coronary sinus, patent LBCV to
RSVC
17 39 Sinus venosus ASD APV RUL and RML to RSVC
18 27 Scimitar syndrome APV RUL, RML, and RLL to IVC Dextrocardia, normal RPA origin, small right
lung
19 30 Sinus venosus ASD APV RUL and RML to RSVC PLSVC to coronary sinus
20 51 Sinus venosus ASD APV RUL and RML to RSVC Bovine aortic arch
APV 5 anomalous pulmonary vein; ASD 5 atrial septal defect; IVC 5 inferior vena cava; LA 5 left atrium; LBCV 5 left brachiocephalic vein; LML 5 left middle lobe; LUL 5
left upper lobe; RPA 5 right pulmonary artery; PLSVC 5 persistent left superior vena cava; PV 5 pulmonary vein; RLL 5 right lower lobe; RML 5 right middle lobe; RSVC 5
right superior vena cava; RUL 5 right upper lobe; VSD 5 ventricular septal defect.
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(maximal gradient strength 5 2.3 Gauss/cm in 150 ms). We
used a custom torso multicoil array surface coil set to
improve signal-to-noise ratio (23). Following scout imag-
ing, a set of interleaved T1-weighted spin echo images
(5-mm thickness with 5-mm skip) was acquired from just
cephalad to the manubrium to the level of the hepatic veins.
ASD IMAGING. We used a combination of techniques for
the assessment of ASD location, size and direction of shunt
flow. An ultrafast ECG-gated multiphase segmented
k-space gradient-echo sequence was used to assess the
structure and potential flow across the interatrial septum,
providing 10 to 14 frames through the cardiac cycle at each
imaging plane (24). Single breath-hold periods of 13 to 18 s
were required at each slice location. Imaging variables
included 26 to 32 cm field of view; 256 3 128 acquisition
matrix interpolated to 256 3 256; 6-mm slice thickness;
echo time (TE) 1.8 to 2.3 ms, repetition time (TR) 6.7 to
8.3 ms; 6 to 8 k-space lines per cardiac frame; number of
signal averages 5 1, digital receiver bandwidth 6 32 kHz;
excitation flip angle 5 30°. Imaging commenced at the site
of potential communication between a suspected APV
(based on spin echo images) and the superior vena cava
(SVC), brachiocephalic vein or other structure, and contin-
ued through the entire interatrial septum. The presence of a
consistent flow disturbance (signal void or moving blood)
from the left atrium to the right atrium at the level of the
high interatrial septum defined a sinus venous ASD
(SVASD). A flow disturbance associated with a defect in
the interatrial septum at the level of the fossa ovalis defined
a secundum ASD. If the diagnosis of ASD was uncertain,
the TE and TR of the segmented k-space sequence was
lengthened to at least twice the nominal values and then
repeated at the level of the most suspicious site. If this was
still unrevealing, a conventional cine gradient echo sequence
was performed (TE approximately 13 ms, TR approxi-
mately 33 ms), followed by a phase-contrast cine MRI
sequence to permit more sensitive flow detection. Quanti-
tative assessment of the ASD size was determined from the
maximum defect size noted on the cine images. The ASD
sizes were designated as follows: small, ,1 cm; moderate, 1
to 1.5 cm; and large, .1.5 cm.
MR ANGIOGRAPHY. We modified a fast 3D spoiled gradient
(SPGR) sequence to minimize TE and TR by decreasing
the width of the radiofrequency pulse used for slice excita-
tion (TE) in a standard fast SPGR sequence from 3.20 to
1.28 ms (14). In addition, first-order gradient-moment
nulling was eliminated and an asymmetric echo was used.
Coronal ultrafast 3D SPGR (UF-3DSPGR) imaging was
performed using the conventional body coil before and after
intravenous administration of a gadolinium-based contrast
agent (gadopentetate dimeglumine, “Magnevist,” Berlex
Laboratories, Cedar Knolls, New Jersey; or gadoteridol,
“Prohance,” Bracco Diagnostics, Princeton, New Jersey)
with the following parameters: TR 5 4.8 to 7 ms; flip angle
60°; matrix size 256 3 128; slice thickness 2 to 4 mm;
receiver bandwidth 64 kHz; and acquisition time 18 to 34 s.
A field of view of 26 to 38 cm was used to include the
majority of the thorax. The patients’ arms were positioned
above the head (coronal plane imaging) or on the abdomen
(sagittal plane imaging) to avoid aliasing. Scans were com-
pleted in 18 to 34 s. Scan time was reduced in those patients
who could not sustain breath-holds for 30 s despite hyper-
ventilation and oxygen by nasal cannula at up to 4 liters/
min. Later software improvements allowed the TE to be
reduced to 1.11 ms (final three patients).
INJECTION. Patients underwent imaging before, during and
twice after intravenous injection of contrast. All patients
received 20 to 40 ml of contrast agent administered intra-
venously, with injections performed by hand using a stop-
watch. Injection rate was modified based on the acquisition
time of the scan to obtain as uniform an arterial contrast
concentration as possible throughout the image acquisition.
Scanning commenced approximately 10 s after contrast
injection in patients with normal right and left ventricular
function (assessed from cine or multiphase GRE images),
and approximately 20 s after injection in patients with
moderate or severe right or left ventricular dysfunction.
IMAGE ANALYSIS. Images were analyzed on an Advantage
Windows workstation (GEMS; Milwaukee, Wisconsin)
featuring interactive 3D reformatting, variable recon-
structed slice thickness and oblique and multiaxis recon-
struction (Fig. 1), and displayed using the maximum inten-
sity projection algorithm (25).
Cardiac catheterization. Nineteen of the twenty patients
(95%) underwent cardiac catheterization to obtain right and
left heart chamber pressures and oxygen saturations. Pulmo-
nary (Qp) and systemic (Qs) blood volume flows and shunt
fractions (Qp/Qs) were calculated. Attempts were made to
cross the interatrial septum with a catheter in all patients.
Selective contrast angiography by hand injection was used to
identify the site of drainage of any suspected APV.
Transesophageal Echocardiography. Transesophageal
echocardiograms were obtained in 12 patients. Images of
the right and left heart chambers (including sizes and
function) were obtained, and attempts were made to define
the entire interatrial septum, all the pulmonary veins, the
vena cavae and coronary sinus in all patients from multiple
views. Doppler color flow mapping and peripheral venous
contrast injections of agitated saline solution were per-
formed to establish the presence, size, location and direction
of blood flow across the interatrial septum.
Comparative data. Data were analyzed using an agreement
analysis that compared the number of instances in which the
different techniques agreed or disagreed for a given test
situation (26). This analytical approach was the most
appropriate since not all patients underwent imaging with
each technique, and not all patients underwent surgical
correction. An overall comparison was performed among
MRI, cardiac catheterization and TEE for detection of
APVs and ASDs.
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RESULTS
Magnetic resonance imaging and angiography. Fast cine
MRI with UF-3DSPGR contrast-enhanced MRA was
performed in all 20 patients without complication. Total
time per patient for completion of all imaging was 58 6
12 min. Partial APVD was demonstrated in 16 of 20
patients and was definitively excluded in four patients. The
region of lung drained by APV involved one pulmonary lobe
in four patients (Fig. 2), two lobes in 10 and the complete
right lung in two. Fifteen APVs were right-sided and one
was left-sided. Drainage of the APV was supracardiac in 13
and infracardiac in three. These latter three patients had
scimitar syndrome, which consisted of drainage of the whole
right lung (in two) and two lobes of the right lung (in one)
via an APV to the inferior vena cava (IVC) (27) (Fig. 3).
One of these patients (not the subject of Fig. 3) was
described in a previous report (28). Four patients had
normal pulmonary venous drainage, of whom one had
Eisenmenger’s syndrome with a nonrestrictive ventricular
septal defect (VSD), one had a restrictive muscular VSD,
one had atresia of the right pulmonary artery (Swyer-James
syndrome) with a secundum ASD and one had a secundum
ASD only.
Seventeen of 20 patients were demonstrated by MRI to
have ASDs, six classified as secundum type and 11 as
SVASDs. All patients (100%) with SVASD had partial
APVD; five of these also had abnormal systemic venous
connections, including a persistent left SVC draining into a
dilated coronary sinus. By contrast, only two of the six
patients with secundum ASDs had APVD; in one patient,
the left upper and middle lobes of the lung drained into the
left brachiocephalic vein (Fig. 4), and in the other patient,
the right upper and right middle lobes drained into the right
SVC.
Cardiac catheterization. Nineteen patients underwent
cardiac catheterization, and there were two complications:
an allergic reaction to the contrast agent consisting of severe
bronchospasm and rash, and development of congestive
heart failure. Six patients had severe pulmonary hyperten-
sion (pulmonary artery systolic pressure .50 mm Hg).
Pulmonary-to-systemic blood flow ratio (Qp/Qs) varied
from 0.75 to 3.4 (mean 2.1 6 0.8) (Table 2). Right atrial
pressure ranged from 2 to 22, with a mean of 6 mm Hg.
Anomalous pulmonary venous drainage was diagnosed at
cardiac catheterization in 12 of the 16 patients by selective
hand injection of contrast; APVD was excluded in two
patients (Table 2).
Atrial septal defect was diagnosed by oximetry and/or
selective contrast angiography in six patients (43%), and was
“suspected” in two additional patients, although the location
and type of defect could not be determined.
Transesophageal echocardiography. Twelve patients un-
derwent TEE, and APVD was diagnosed in seven patients,
Figure 1. The magnetic resonance angiography 3D data set is collected as
a series of contiguous slabs in either the coronal or sagittal plane. The
contrast-enhanced data set shown is a coronal acquisition with the most
anterior images to the left of the stack and the posterior structures to the
right. Selected images from the data set demonstrate an anomalous right
upper pulmonary vein entering the superior vena cava just above the
junction with the right atrium (arrow, left), and the right lower lobe
pulmonary vein entering the left atrium normally (arrow, right). RLL 5
right lower lobe; RUL 5 right upper lobe.
Figure 2. Figure 2 shows a reformatted oblique coronal magnetic reso-
nance angiography (MRA) from the data set in Figure 1 that now
demonstrates the more complete course of the right upper lobe pulmonary
vein (RUL). In this patient with anomalous pulmonary venous return from
one lobe, the RUL enters the superior vena cava at a level 1.4 cm superior
to the right atrium (arrow). All MRA images in this report are displayed
as reformatted maximal intensity projection images.
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although the specific lung segments drained could not
always be determined.
An ASD was definitively identified in eight (67%), and in
another patient, the presence of a SVASD was “suspected”
but not confirmed. Transesophageal echocardiography ex-
cluded ASD in one patient, but misclassified two SVASDs
as normal.
ASD size. The estimated ASD size by MRI correlated well
with shunt fraction measurements by catheterization (Table
3), with no major discrepancies noted. There was 89%
agreement for shunts .1.5:1 (MRI identified one shunt of
1.7:1 as small rather than moderate). One artifactual dis-
agreement occurred in a patient with Eisenmenger’s phys-
iology and right-to-left shunting. There was 100% agree-
ment for shunts of ,1.5:1. One patient underwent
catheterization at age 10 years with a calculated shunt of
2.5:1 identified as an APV only, but 17 years later had a
small, very superiorly located SVASD by TTE and MRI
with slightly dilated right heart chamber sizes and a normal
estimated pulmonary artery (PA) systolic pressure.
Surgical intraoperative findings. Ten patients underwent
surgical correction of APVs and/or closure of the ASDs,
and the intraoperative findings are outlined in Table 1. The
anatomic findings at surgery confirmed those obtained by
MRI and MRA in all cases (100%), including ASD size. In
this subgroup of patients with surgical correlation (Table 2),
the predictive diagnostic accuracy of TEE for APV was
80%, and 78% for cardiac catheterization. For detection of
ASDs, the predictive diagnostic accuracy of TEE was 80%,
and 44% for catheterization. Ten patients did not undergo
surgical repair: four because of severe pulmonary hyperten-
sion (one of whom died suddenly without autopsy, three are
currently listed for lung transplantation), one was not a
surgical candidate due to severe chronic obstructive pulmo-
nary disease and five did not undergo surgical closure
because the intracardiac shunt was small (Qp:Qs , 1.5:1)
with only minimal elevation of PA pressures.
Agreement analysis. Table 4 summarizes the agreement
analysis. Specific comments for each anomaly follow.
APV. There were two false positive and three false negative
errors by catheterization. In the false positive patients, one
(Patient 1) had right PA atresia and an ectatic course of the
left upper pulmonary vein, which when crossed via the
Figure 3. (A) Oblique coronal image through a 3D dataset, showing an
anomalous pulmonary vein formed by the right upper and right middle
pulmonary veins that courses through the right thorax and enters the
inferior vena cava below the level of the diaphragm (arrow). Despite the
large field of view and the fact that the vessel crosses the diaphragm, the
vessel’s course is clearly depicted. (B) Right lower lobe pulmonary vein
enters the left atrium normally (arrow). The right pulmonary artery is
identified by the open arrow.
Figure 4. Reformatted oblique section of a 3D contrast-enhanced mag-
netic resonance angiography data set demonstrating anomalous connection
of the left upper and left middle pulmonary veins to a vertical vein that
enters the left brachiocephalic vein (BcphV). Communication between the
BcphV and the right superior vena cava (SVC) is seen proximal to the entry
of the SVC into the right atrium. The aorta and left pulmonary artery (PA)
are also noted. This figure demonstrates the utility of the reformatting
technique, which permits reorientation of the data set from a coronal
(original) to an oblique parasagittal view and delineation of the course of
nearly the entire BcphV. APV 5 anomalous pulmonary vein.
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unsuspected ASD appeared to be an APV. Another (Patient
11) had angiography of a suspected right upper lobe (RUL)
APV, but the catheter had crossed the ASD and entered the
normally draining RUL pulmonary vein, which entered the
left atrium at a more superior location than typical. The
false negative patients all had high SVASDs (two of three
were significant in size), that were oriented such that they
could not be negotiated or crossed by catheter, and whose
shunts were ascribed to APVs.
There were three false negatives by TEE, two due to high
insertion of the APV (.2.0 cm above the right atrium) into
the SVC, and the third a left upper and middle lobe APV
draining to the brachiocephalic vein (Fig. 4).
ASD. Catheterization and MRI agreed in only 10 of 19
(53%) cases, and disagreed in 8 of 19 (37%), all cases being
false negatives (mean shunt ratio 2.5:1). One patient’s
catheterization report did not specifically comment on the
presence or absence of an ASD. In eight further patients, six
with sinus venous and two with small secundum defects, the
ASD was not diagnosed either by oximetry or by crossing
the atrial septum at catheterization. Four of six SVASDs
were located high in the interatrial septum; however, two
were crescent-shaped due to an extensive defect of the upper
septum, yet still could not be crossed by a catheter. Both
patients with small secundum defects also had APVs, one
with a left-sided APV (Fig. 4), and the other had associated
severe pulmonary hypertension.
There were two false negative studies with TEE. Both
patients had high SVASDs that could not be fully visualized
on TEE, but were well delineated on MRI and confirmed
by surgery.
DISCUSSION
The major finding in this prospective study is that our
modified imaging methods using fast segmented k-space
imaging and contrast-enhanced ultrafast 3D MRA allowed
unequivocal detection of APVs and ASDs in a population of
Table 2. Demographic Information and Diagnostic Testing Results
Patient
No. Age, yr Gender Op PAP Shunt
MRI TEE Cath
ASD APV ASD APV ASD APV
1 54 F 80/16 * 1 o 2 2 1 1
2 53 F x 44/18 2.4:1 1 1 o 1 o 1
3 39 F x 2 2 1 1 o o 2 2
4 56 F 100/40 1.5:1 1 1 2 2 o 1
5 68 F 30/12 1.7:1 1 1 1 o o 1
6 55 M x 30/10 3.0:1 1 1 1 1 o 1
7 27 M 20/8 2.6:1† 1 1 2 2 o 1
8 38 F x 25/9 2.5:1 o 1 o 1 2 1
9 35 F x 69/22 2.9:1 1 1 1 1 o o
10 29 M 34/12 1.2:1 1 o 2 2 1 o
11 59 M x 37/16 1.7:1 1 o 1 o 1 1
12 42 M x 38/22 3.4:1 1 1 1 o 1 1
13 28 M 100/60 0.75:1 1 o 1 o 1 o
14 47 F 34/13 1.2:1 o 1 2 2 o 1
15 49 F x 52/21 3.0:1 1 1 1 1 1 1
16 22 M 22/10 1.0:1 1 1 2 2 o o
17 39 M x 24/8 3.2:1 1 1 1 1 o 1
18 27 M 36/6 1.7:1 o 1 2 2 o 1
19 30 F 104/46 2 1 1 2 2 1 o
20 51 F x 28/10 2.6:1 1 1 1 1 1 1
*Unable to calculate: procedure aborted after 230 ml contrast agent use and pulmonary edema. †Catheterization at age 10 years, see Table 3.
APV 5 anomalous pulmonary vein; ASD 5 atrial septal defect; Cath 5 cardiac catheterization; MRI 5 magnetic resonance imaging; Op 5 operative repair of defect(s);
PAP 5 pulmonary artery pressure (systolic/diastolic, mm Hg); TEE 5 transesophageal echocardiography; 1 5 present or detected as present; o 5 absent or detected as absent;
2 5 not performed or not commented on.
Table 3. Atrial Septal Defect Size by MRI Magnetic Resonance
Imaging Versus Shunt Fraction
ID No. Shunt MRI
1 * L
2 2.4:1 nc
3 2 L
4 1.5:1 S
5 1.7:1 nc
6 3.0:1 M
7 2.6:1† S
8 2.5:1 o
9 2.9:1 M
10 1.2:1 S
11 1.7:1 S
12 3.4:1 L
13 0.75:1 M
14 1.2:1 o
15 3.0:1 M
16 1.0:1 S
17 3.2:1 L
18 1.7:1 o
19 nc nc
20 2.6:1 L
*Shunt could not be calculated at catheterization. †Catheterization at age 10 years;
shunt appeared significantly smaller 17 years later.
2 5 no catheterization performed; L 5 large; M 5 moderate; MRI 5 magnetic
resonance imaging; nc 5 not commented on; o 5 no ASD present; S 5 small.
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patients in whom diagnosis was inconclusive by cardiac
catheterization and TEE. The advantages of this technique
include imaging of a larger anatomic area than possible by
TEE or catheterization and rapid data acquisition in a single
breath-hold, which are important for imaging vascular
structures within the thorax. Magnetic resonance angiogra-
phy enables PAs and pulmonary veins to be differentiated
and provides visualization of even the small pulmonary
venous radicles, permitting determination of the number of
anomalously draining pulmonary lobes. Furthermore, the
entire course of the APV can be followed from the periphery
through the hilum and mediastinum to their drainage sites.
Accurate identification of APVD patterns is important since
the surgical correction of APVs from the right upper and
middle pulmonary lobes is different from that for infracar-
diac drainage or left-sided APVs (20). Noninvasive defini-
tion of retrocardiac or infracardiac pulmonary venous drain-
age and the anatomy of the lung from which the anomalous
drainage derives is possible only with MRA (29).
Difficulties in diagnosing APVs may occur with TTE or
TEE and cardiac catheterization. Restricted acoustic win-
dows limit the use of TTE, and dilution of hand-injected
angiographic contrast or levophase angiography at cardiac
catheterization limits visualization of the pulmonary veins.
Catheterization is also limited by the inability to distinguish
an ASD from an APV when oximetry indicates an intra-
cardiac shunt at atrial level if the ASD cannot be crossed
with a catheter. Crescent-shaped SVASDs or those high in
the atrial septum may be difficult to cross and thereby escape
detection by catheterization, and in this study accounted for
most of the eight false negatives at catheterization, despite a
significant shunt fraction (mean Qp:Qs 5 2.5:1). Although
TEE enables inspection of the entire interatrial septum, the
predictive accuracy of TEE for detection of normal and
anomalous pulmonary veins has varied widely from 60% to
93% (3), and in our study was 75% (Fig. 5). Anomalous
pulmonary veins that insert .2 cm above the right atrium or
left-sided APVs were particularly difficult to detect in our
study. Furthermore, the presence of four pulmonary veins
does not exclude the presence of additional APVs (2), and
recognition of multiple branching APVs or atypical drain-
age patterns are difficult to achieve by TEE (8). Also, TEE
provides only limited information regarding the extent or
region of the lung that has abnormal drainage (2,8).
Two previous small studies have demonstrated the utility
of MRI in identifying the presence of APVs (9,10), and
another suggested that the technique was limited in adults
with congenital heart disease (20); however, these studies
used older and less sensitive methods. A recent article
compared spin echo to gradient echo MRI acquisition in
detection of APVs, but was limited to axial or coronal
orientations (12). We developed a modified MRI pulse
sequence to permit high-resolution 3D imaging of nearly
the entire thorax in one breath-hold, which is especially
useful for detecting abnormal vascular communications
outside the usual echocardiographic windows (8), and used
an image workstation that allowed improved 3D reconstruc-
tion and visualization of the vasculature.
In this study, we made the initial tacit assumption that
Table 4. Agreement Analysis
APV
Agree Disagree
Cath (n 5 19) TEE (n 5 12) Cath TEE
MRI 14 (74%) 9 (75%) 5 (26%) 3 (25%)
Sensitivity (vs. MRI) 80% 70% 2 FP, 3 FN 3 FN
Specificity (vs. MRI) 50% 100%
ASD
Agree Disagree
Cath (n 5 19) TEE (n 5 12) Cath TEE
MRI 10 (53%) 10 (83%) 8 (37%) 2 (17%)
Sensitivity 50% 82% 8 FN 2 FN
Specificity 100% 100%
APV 5 anomalous pulmonary vein; ASD 5 atrial septal defect; Cath 5 cardiac catheterization; FN 5 false negative; FP 5 false positive; MRI 5 magnetic resonance imaging;
TEE 5 transesophageal echocardiography. Sensitivity and specificity measurements calculated vs. MRI as reference standard.
Figure 5. Axial spin echo MRI demonstrating a sinus venosus defect
(arrow) just caudal to the insertion of the superior vena cava and between
the right atrium (RA) and left atrium (LA). Due to its location high in the
atrium, it is sometimes difficult to cross with a catheter or to visualize with
transesophageal echocardiography (TEE). This defect was misidentified on
both catheterization and TEE examinations.
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MRA was the reference standard before we analyzed the
data obtained at cardiac catheterization, TTE and TEE or
reviewed the intraoperative findings. The intraoperative
findings in all 10 surgical patients were completely concor-
dant with the MRA findings. The definitive diagnosis of
ASD and APVD was established by cardiac catheterization
in 53% and 74% of patients, respectively, compared to MRI
and by echocardiography (TTE and/or TEE) in 83% and
75%, respectively. Both techniques had false positive and
false negative diagnoses. Magnetic resonance angiography
demonstrated that most patients (94%) had right-sided
APVs, 75% of the APVs involved two or more lobes and
25% were from single lobes. Transesophageal echocardiog-
raphy was not helpful in making a definitive diagnosis of
infracardiac pulmonary venous drainage to the IVC, al-
though this was suspected in two cases. Both cardiac
catheterization and echocardiography identified the five
patients with severe pulmonary hypertension, one of whom
died from end-stage right heart failure (Patient 1) and two
of whom are currently listed for lung transplantation (Pa-
tients 4 and 13). Quantitative assessment of PA pressures
and direction of intracardiac shunt flow by cardiac cathe-
terization plays an important role in determining the need
for surgical correction, and our MRI and MRA methods in
this study were used as an adjunct to catheterization in this
decision process.
Newer methods have demonstrated that MRI techniques
can accurately quantitate the size and degree of shunting of
ASDs, and may soon permit a completely noninvasive
preoperative assessment (18,30,31).
Study limitations. The small sample size limits the more
general applicability of our findings; however, despite this
fact, important concepts and pitfalls of conventional imag-
ing techniques were revealed. The dramatic difference in
performance between MRI and standard methods may be
due to selection of patients in whom conventional detection
strategies failed; however, the surgical confirmation of the
results lends support to the overall accuracy of the method.
The MRA technique is not cardiac-gated, which may
obscure small areas of interest, and therefore requires the use
of additional gated sequences for accurate quantitation of
ASD size and visualization of flow direction.
CONCLUSIONS
We have demonstrated that our new MRA imaging strat-
egy, which is performed in a single breath-hold, can resolve
the residual diagnostic problems in adult patients with
ASDs and APVD. This challenging subgroup of patients
requires highly accurate diagnostic testing to provide appro-
priate therapeutic guidance. These data underscore the
importance of accurate identification of the pulmonary
veins, especially in patients identified as having secundum
ASDs and believed to be candidates for minimally invasive
surgical or catheter-based closure procedures. We recom-
mend the use of new ultrafast MRA and MRI techniques
for patients in whom diagnosis remains inconclusive after
cardiac catheterization, TEE or both.
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